ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

This study is currently recruiting participants.
Study NCT00199628.   Last updated on March 10, 2006.   Information provided by University Hospital, Limoges

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Official Title  Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Brief Summary

Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus.

The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism.

The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.

Detailed Description
Study Phase
Study Type  Observational
Study Design  Longitudinal, Defined Population, Prospective Study
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Glomerulonephritis, Membranous
Neonatal Diseases and Abnormalities
Hemochromatosis
Intervention 
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  100
Start Date  September 2005
Completion Date
Eligibility Criteria 

Inclusion Criteria:

Mothers having a child suffering from:

  • Neonatal membranous glomerulonephritis
  • Unexplained neonatal tubular defect
  • Unexplained thrombotic microangiopathy
  • Neonatal hemochromatosis

Exclusion Criteria:

  • Any cause explaining the child's disease
Gender Female
Ages
Accepts Healthy Volunteers No
Contacts ††
Contact: Vincent Guigonis, MD     +33(0)555 056 358     vincent.guigonis@chu-limoges.fr    
Location Countries  France
Administrative Information Fields
NCT ID  NCT00199628
Organization ID I05001
Secondary IDs ††
Study Sponsor  University Hospital, Limoges
Collaborators ††
Investigators 
Principal Investigator:     Vincent Guigonis, MD     Department of Pediatrics, Limoges University Hospital    
Information Provided By University Hospital, Limoges
Verification Date September 2005
First Received Date  September 14, 2005
Last Updated Date March 10, 2006

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers